Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Shasun Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 428.55 21.95  | 5.40% 102.05% 63.83 2,884.25
NSE Price: Nov 17, 2015 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 17, 2015 428.55 21.95 5.40% 410.60 406.60 507,063 408.00 - 433.00
BSE Nov 17, 2015 428.85 22.50 5.54% 410.00 406.35 79,828 407.80 - 432.05
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 208,530 P/B: 5.99 NSE Code: SHASUNPHAR
52-Week Range: R 209.40 - 433.00 Dividend Yield: 0.00% BSE Code: 524552
TTM EPS: R 6.72 Book Value: R 71.62 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.57 7.28 10.92
Net Profit -21.17 -38.11 44.63
EPS -25.95 -39.95 38.34
Book Value 11.90 14.54 19.58
Average
Operating Margin 10.03 11.13 11.99
Net Margin 1.79 3.02 4.25
Return on Networth 7.25 13.22 26.58
Return on Investment 8.82 9.76 13.47
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 1.72 6.04 -
Operating Profit 30.68 75.70 -
Net Profit 243.83 907.69 -
EPS 244.45 4,579.09 -
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Shasun Pharmaceuticals 2,884.25 1,074.42 44.72 4.11 7.25 5.99 63.83
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 08, 2015 Sequent Scientific Ltd  Buy Conv. of Share 7,100,000 351.85 24,981.35
Dec 24, 2014 Ambematha Securities  Buy Market 1,541,313 273.00 4,207.78
Dec 24, 2014 Chayadeep Properties Pvt. Ltd.  Sell Market 1,541,313 273.00 4,207.78
Sep 15, 2014 D Sajjan  Buy Off Market 158,000 200.20 316.32
Sep 02, 2014 Morgan Stanley Asia (Singapore) Pte  Sell Market 308,074 209.70 646.03
Fund Houses invested in the stock
Fund Sep-15 Jun-15 Mar-15 Dec-14 Sep-14
Sundaram Mutual Fund 3.167 3.137 3.618 3.330 2.743
SBI Mutual Fund 0.595 - - - -
Aditya Birla Sun Life Mutual Fund 0.400 0.400 0.412 0.499 -
Kotak Mahindra Mutual Fund 0.376 0.234 0.259 0.259 0.259
UTI Mutual Fund 0.080 0.122 0.149 0.172 0.172
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Shasun Pharmaceuticals Ltd.

Address: Batra Centre, 28, Sardar Patel Road, Guindy, Chennai, Tamil Nadu - 600032 | Phone: 91-44-43446700 | Fax: 91-44-22350924/ 22350278

Email: [email protected]

Website: www.shasun.com

Registrar & Transfer Agent: Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

Address: II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai, II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar | Phone: 044-28140801 | Fax: 044-28142479

Email: [email protected]

Essential checks
Altman Z-Score
2.89
Piotroski F-Score
5
Modified C-Score
3
1-Year Price to Earnings
63.83
1-Year Price to Book
5.99
Earnings Yield
EBIT / Enterprise value
2.57%
PEG
Price / Earnings to growth ratio
0.81